What is the softgel capsules market growth?
The Softgel capsule market Size was valued at USD
7.3 billion in 2021 and is projected to grow from USD 7.87 Billion in 2022 to
USD 13.9 billion by 2032, exhibiting a compound annual growth rate (CAGR) of
7.7% during the forecast period (2023 - 2032).
Soft gel capsules are used to encapsulate liquid or semi-liquid active ingredients for a wide range of
pharmaceutical compounds. The market for soft gel capsules are expected to grow
due to its easy manufacturing process, and the growing demand for nutraceutical
products such as nutritional supplements among the health-conscious population.
The growing number of pharmaceutical market players is also expected to create
lucrative opportunities and increase the demand for soft gel capsules, thus
contributing to the exponential growth over the forecast period.
Rapid expansion of the pharmaceutical sector, alongside increased
healthcare expenditure, has opened new avenues for market players. Besides,
regulatory and technological advances are leveraging the benefits of
large-scale manufacturing with a high degree of flexibility for
personalization, in turn, fostering the market growth. Additional factors, such
as increasing personalization of therapies and substantial investments made in
R&D for innovations to accelerate the production flow, are supporting the
growth of the market. On the other hand, high manufacturing cost and complexity
of production are some of the factors posing challenges for the growth of the
market. Also, unclear regulatory policies in many countries are significant
constraints for the growth of the global Softgel
Capsule Market. Nevertheless, multiplying numbers of
pharma companies that can manufacture a softgel capsule market at a
high production rate are some of the major factors that would support the
growth of the market by bringing the production cost down.
Softgel Capsule Market Segmentation
The global soft gel capsule has been segmented
based on type and application.
Based on type, the soft gel capsule market is
segmented into gelatin type and non-animal type. The gelatin type segment is
expected to grow as the largest market share, owing to their easy-to-use
features for the administration of drugs orally or with the use of inhalation
routes. The non-animal types segment is projected to witness a comparatively
higher CAGR during the forecast period.
On the basis of application, the softgel market
has been segmented into nutrition, supplement, and vitamins. The vitamins
segment is expected to contribute to more than 30% of the market share during
the forecast period, owing to the increased prevalence of vitamin deficiency, which is expected to fuel the growth of the
segment. The nutrition segment is expected to exhibit the highest CAGR over the
forecast period, owing to the high malnutrition rate underdeveloped and
developing countries, leading governments to initiate awareness programs and subsidies
products.
Softgel Capsule Market Regional
Analysis
Based on the region, the global soft gel
capsule market has been segmented into North
America, Europe, Asia Pacific (APAC), Latin America (LATAM), and the Middle
East and Africa (MEA).
North America is the largest region in the global
soft gel capsule market and is expected to sustain its market standing over the
forecast period, owing to the growing preference of capsules dosage among
consumers, growth in consumer awareness regarding the benefits of nutraceutical
products to prevent significant health disorders, established pharmaceutical in
the region, and the increasing government initiatives to ensure the superior
quality of medical facilities offered to the consumers.
Europe is one of the significant regions in the
global market for soft gel capsules and is expected to contribute substantially
to the market share over the forecast period, owing to the established
healthcare sector, accessibility of superior medical facilities,and the
increasing health consciousness among consumers.
The Asia Pacific is the fastest growing regions in
the global soft gel capsule market, owing to the government initiatives to
enhance the healthcare sectors, especially in emerging economies such as India,
Japan, and China.
The Middle East and Africa (MEA) region is
expected to witness gradual growth of the forecast period and account for the
smallest market share, due to the weak healthcare sector in Africa, and
unfavorable factors for market growth such as weak economic and political
conditions. The developing Middle Eastern countries such as Saudi Arabia and
the United Arab Emirates are expected to contribute to the majority of the
market share, owing to the presence of a developing healthcare and
pharmaceutical sectors.
Key Players
Softgel
Capsule Market Players are Amway,
Capsugel (a part of Lonza), Captek softgel International Inc., Catalent, Inc.,
EuroCaps Ltd. (part of the DCC plc Group), International Vitamin Corporation,
Patheon (part of Thermo fisher scientific), Sirio Pharma Co. Ltd., Soft Gel
Technologies, Inc., Strides Pharma Science Limited, Weihai Baihe Biology
Technological Co. Ltd.
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street, 5Th Floor,
New
York, New York 10013
United
States of America
+1
628 258 0071
Email:
sales@marketresearchfuture.com
0 Comments